U.S. court voids $448 million award against AbbVie, AndroGel partner

Ruling in a case brought by the Federal Trade Commission, the 3rd U.S. Circuit Court of Appeals in Philadelphia said the lower court judge who ordered the disgorgement by AbbVie and Besins Healthcare Inc lacked authority under applicable federal law. The appeals court also upheld an order finding AbbVie and Besins liable for monopolization, based upon its holding that they had filed a sham patent infringement lawsuit against Perrigo Co to delay the launch of generic AndroGel. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.